Zobrazeno 1 - 10
of 257
pro vyhledávání: '"Treat to target"'
Autor:
Esther Beckers, Annelies Boonen, Astrid van Tubergen, Casper Webers, Harald E. Vonkeman, Peter M. ten Klooster, M. Efde
Publikováno v:
Rheumatology, 61(4), 1396-1407. Oxford University Press
Rheumatology. Oxford University Press
Rheumatology. Oxford University Press
Objectives To evaluate the extent to which internationally agreed treat-to-target recommendations were applied in clinical practice in patients with axial spondyloarthritis. Methods Data were used from a web-based patient registry for monitoring SpA
Autor:
Myrto Kostopoulou, Manuel F Ugarte-Gil, Bernardo Pons-Estel, Ronald F van Vollenhoven, George Bertsias
Publikováno v:
Kostopoulou, M, Ugarte-Gil, M F, Pons-Estel, B, van Vollenhoven, R F & Bertsias, G 2022, ' The association between lupus serology and disease outcomes : A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus ', Lupus, vol. 31, no. 3, pp. 307-318 . https://doi.org/10.1177/09612033221074580
Introduction Serological markers such as anti-double stranded (ds)DNA antibodies and complement fractions C3/C4, are integral components of disease activity assessment in patients with systemic lupus erythematosus (SLE). However, it remains uncertain
Autor:
Ahmed Al Hasan, Floor Reimann, Nic J. G. M. Veeger, Sytske Anne Bergstra, Dan Zhang, Arno R. Bourgonje, Lidy Hendriks, Titus Beertsen, Liliane Zari Riofrio, Freke Wink, Annemarie Schilder, Tom W. J. Huizinga, Reinhard Bos
Publikováno v:
Rheumatology International. SPRINGER HEIDELBERG
Rheumatology International
Rheumatology International
The Handscan is a novel objective optical imaging device for disease follow-up and management in rheumatoid arthritis patients. We aim to examine the association between the baseline outcomes of the Handscan, disease activity levels and joint swellin
Autor:
Toshiyuki Baba, Yuichi Mori, Shin-ei Kudo, Yasuharu Maeda, Yuki Takashina, Kazumi Takishima, Yoshika Akimoto, Masashi Misawa, Toyoki Kudo, Kenta Tanaka, Seiko Sasanuma, Tetsuo Nemoto, Takemasa Hayashi, Mayumi Homma, Hiroki Nakamura, Yuki Miyata, Fumio Ishida, Kazuo Ohtsuka, Noriyuki Ogata, Katsuro Ichimasa, Kentaro Mochida, Kunihiko Wakamura, Hideyuki Miyachi
Publikováno v:
Digestive Endoscopy. 34:1030-1039
Objectives Complete endoscopic healing, defined as Mayo endoscopic score (MES)=0, is an optimal target in the treatment of ulcerative colitis (UC). However, some patients with MES=0 show clinical relapse within 12 months. Histologic goblet mucin depl
Publikováno v:
JCR: Journal of Clinical Rheumatology. 28:321-324
Publikováno v:
Advances in Therapy
The treat-to-target strategy, which defines clinical remission as the primary therapeutic goal for rheumatoid arthritis (RA), is a widely recommended treatment approach in clinical guidelines. Achieving remission has been associated with improved cli
Autor:
Gulen Hatemi
Publikováno v:
Current Opinion in Rheumatology. 34:39-45
PURPOSE OF REVIEW Treat-to-target (T2T) approach has improved outcomes in chronic diseases. The aim of this review is to discuss the long-term goals and review the evidence for possible targets that would predict the achievement of these goals for de
Autor:
Piet Geusens, Enrique Casado, Thierry Thomas, Lorenz C. Hofbauer, D. Taylor, W. F. Lems, J. Timoshanko
Publikováno v:
Osteoporosis International, 31(12), 2303-2311. Springer-Verlag London Ltd.
Osteoporosis International
Osteoporosis International, 31(12), 2303-2311. Springer London
Thomas, T, Casado, E, Geusens, P, Lems, W F, Timoshanko, J, Taylor, D & Hofbauer, L C 2020, ' Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts ', Osteoporosis International, vol. 31, no. 12, pp. 2303-2311 . https://doi.org/10.1007/s00198-020-05569-9
Osteoporosis International
Osteoporosis International, 31(12), 2303-2311. Springer London
Thomas, T, Casado, E, Geusens, P, Lems, W F, Timoshanko, J, Taylor, D & Hofbauer, L C 2020, ' Is a treat-to-target strategy in osteoporosis applicable in clinical practice? Consensus among a panel of European experts ', Osteoporosis International, vol. 31, no. 12, pp. 2303-2311 . https://doi.org/10.1007/s00198-020-05569-9
A panel of European experts was convened to establish consensus on a treat-to-target strategy in osteoporosis. Panellists agreed that the ultimate goals of treating osteoporosis are recovering pre-fracture functional level and reducing subsequent fra
Publikováno v:
Nature Reviews Rheumatology. 17:565-576
In patients with axial spondyloarthritis (axSpA), pain, functional and structural impairments, reduced mobility and potential deformity of the axial skeleton are the most prominent health concerns. Limitations in physical function and spinal mobility
Publikováno v:
Autoimmunity reviews. 21(10)
The treat-to-target strategy has been recently suggested in the management of Systemic Lupus Erythematosus (SLE). Lupus Low Disease Activity State (LLDAS) and Definitions Of Remission In SLE (DORIS) remission were outlined as two concentric targets.